2. Cardiovascular Disease

Cardiovascular Disease

Cardiovascular Disease

Related Products

PDF 32.36 MB

Cardiovascular diseases (CVDs) are the leading causes of death and disability worldwide. CVDs include diseases of the heart, vascular diseases of the brain and diseases of blood vessels. Caused by atherosclerosis, coronary heart disease and cerebrovascular disease are the most common forms of CVDs. Other less common forms of CVDs include rheumatic heart disease and congenital heart disease. A large percentage of CVDs is preventable through the reduction of behavioral risk factors such as tobacco use, physical inactivity and unhealthy diet. Dietary sodium reduction can alleviate the long-term risk of cardiovascular disease events. Statin therapy is an effective intervention in both the primary and secondary preventions of CVDs in those who are at high risk.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-101682
    SCH 42495 136511-43-8 98%
    SCH 42495 is an orally active neutral metalloendopeptidase (NEP) inhibitor with antihypertensive effect. SCH 42495 is the orally active ethylester proagent of SCH 42354.
    SCH 42495
  • HY-101759
    Isoxsuprine-monoester-1 67160-74-1 98%
    Isoxsuprine-monoester-1, a monoester of isoxsuprine, is a long acting peripheral vasodilator.
    Isoxsuprine-monoester-1
  • HY-U00135
    Calcium channel-modulator-1 136941-70-3 98.77%
    Calcium channel-modulator-1 is an orally active calcium channel modulator that blocks aortic contraction with an IC50 of 0.8 μM. Calcium channel-modulator-1 can be used for the study of cardiovascular conditions.
    Calcium channel-modulator-1
  • HY-U00354
    CP-060 180090-15-7 98%
    CP-​060 is a potent Ca2+ antagonist, inhibits Ca2+ overload and possesses antioxidant and cardioprotective activities.
    CP-060
  • HY-101644
    Saterinone 102669-89-6 98%
    Saterinone is a phosphodiesterase III (PDE III) inhibitor.
    Saterinone
  • HY-101690
    QF0301B 149247-12-1 98%
    QF0301B is an α1 adrenergic receptor antagonist and a low α2 adrenoceptor, 5-HT2A, and histamine H1 receptor blocker.
    QF0301B
  • HY-101729
    Anti-Heart Failure Agent 1 142648-47-3 98%
    Anti-Heart Failure Agent 1 an orally available compound suitable for the treatment of heart failure without inducing nausea, vomiting and restlessness.
    Anti-Heart Failure Agent 1
  • HY-101750
    Arrhythmias-Targeting Compound 1 335619-12-0 98%
    Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.
    Arrhythmias-Targeting Compound 1
  • HY-U00039
    Desethyl KBT-3022 101001-72-3 98%
    Desethyl KBT-3022 is the main active metabolite of the new antiplatelet agent, KBT-3022.
    Desethyl KBT-3022
  • HY-U00040
    PAF-AN-1 115621-84-6 98%
    PAF-AN-1 is a platelet activating factor receptor (PAF) antagonist.
    PAF-AN-1
  • HY-U00086
    Darodipine 72803-02-2 98%
    Darodipine (PY 108-068, PY-108068) is a potent calcium channel antagonist.
    Darodipine
  • HY-U00110
    MG 1 148274-76-4 98%
    MG 1 is an α1 adrenergic receptor antagonist.
    MG 1
  • HY-U00113
    Bunaftide 32421-46-8 98%
    Bunaftide (Bunaftine; Bunaphtide; Meregon) is an antiarrhythmic agent.
    Bunaftide
  • HY-U00136
    Win-62005 152633-54-0 98%
    Win-62005 is a cyclic AMP phosphodiesterase III (PDE III) inhibitor with Kis of 25 and 26 nM for rat heart and canine aorta, respectively.
    Win-62005
  • HY-U00143
    N-0861 racemate 121241-87-0
    N-0861 racemate is the racemate of N-0861. N-0861 is a selective adenosine A1 receptor antagonist.
    N-0861 racemate
  • HY-U00147
    Nicotinoyl cyclandelate 39537-99-0 98%
    Nicotinoyl cyclandelate can be used to lower the perfusion pressure of cerebral blood vessels and the blood pressure of femoral artery.
    Nicotinoyl cyclandelate
  • HY-U00149
    Drobuline hydrochloride 68162-52-7 98%
    Drobuline hydrochloride is an anti-arrhythmic agent with cardiac depressant.
    Drobuline hydrochloride
  • HY-U00151
    Dopropidil 79700-61-1 98%
    Dopropidil is a novel anti-anginal calcium ion modulating agent, possessing intracellular calcium antagonist activity and anti-ischemic effects in several predictive animal models.
    Dopropidil
  • HY-U00173
    U89232 134017-78-0 98%
    U-89232 appears to be a cardioselective KATP channel opener.
    U89232
  • HY-U00182
    DU717 59943-31-6 98%
    DU-717 is an antihypertensive agent.
    DU717
Cat. No. Product Name / Synonyms Application Reactivity